Array
(
[0] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1691417888:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4441
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] => 1
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Risperiget™ (Risperidone) is indicated for the treatment of:
- Treatment of Schizophrenia and other psychotic disorders
- Treatment of moderate to severe manic episodes associated with bipolar disorders
- Short-term treatment only of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and only when there is a risk of harm to self or others
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Risperidone
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antipsychotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 437
[rank_math_primary_filters] => 654
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_type] => Film Coated Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 1MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 2MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 3MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_3_products_strengths] => 4MG
[_getz_products_attributes_0_product_availability_3_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_3_product_link] =>
[_getz_products_attributes_0_product_availability_3_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 4
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[multiple_leaflets_0_leaflet_title] => Prescribing Information
[_multiple_leaflets_0_leaflet_title] => field_5858c432751a4
[multiple_leaflets_0_leaflet_file] => 4414
[_multiple_leaflets_0_leaflet_file] => field_5858c43e751a5
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4383
[ID] => 4383
[post_author] => 19
[post_content] => Risperiget™ (Risperidone) is indicated for the treatment of:
- Treatment of Schizophrenia and other psychotic disorders
- Treatment of moderate to severe manic episodes associated with bipolar disorders
- Short-term treatment only of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and only when there is a risk of harm to self or others
[post_date] => 2022-12-28 08:49:39
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Risperiget™
[post_type] => product
[slug] => risperiget
[__type:protected] =>
[_edit_lock] => 1691417888:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 11
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4441
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] => 1
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Risperiget™ (Risperidone) is indicated for the treatment of:
- Treatment of Schizophrenia and other psychotic disorders
- Treatment of moderate to severe manic episodes associated with bipolar disorders
- Short-term treatment only of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and only when there is a risk of harm to self or others
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Risperidone
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antipsychotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 437
[rank_math_primary_filters] => 654
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_type] => Film Coated Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 1MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 2MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 3MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_3_products_strengths] => 4MG
[_getz_products_attributes_0_product_availability_3_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_3_product_link] =>
[_getz_products_attributes_0_product_availability_3_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 4
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[multiple_leaflets_0_leaflet_title] => Prescribing Information
[_multiple_leaflets_0_leaflet_title] => field_5858c432751a4
[multiple_leaflets_0_leaflet_file] => 4414
[_multiple_leaflets_0_leaflet_file] => field_5858c43e751a5
[post_date_gmt] => 2022-12-28 08:49:39
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => risperiget
[to_ping] =>
[pinged] =>
[post_modified] => 2023-08-02 11:24:26
[post_modified_gmt] => 2023-08-02 11:24:26
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4383
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[1] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1691417938:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4415
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Olanzaget™ (Olanzapine + Fluoxetine) is indicated for the treatment of:
- Acute depressive episodes in Bipolar I Disorder.
- Treatment resistant depression (Major Depressive Disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Olanzapine + Fluoxetine
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antipsychotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 688
[rank_math_primary_filters] => 689
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 3mg+25mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 6mg+25mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4384
[ID] => 4384
[post_author] => 19
[post_content] => Olanzaget™ (Olanzapine + Fluoxetine) is indicated for the treatment of:
- Acute depressive episodes in Bipolar I Disorder.
- Treatment resistant depression (Major Depressive Disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
[post_date] => 2022-12-28 08:22:46
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Olanzaget™
[post_type] => product
[slug] => olanzaget
[__type:protected] =>
[_edit_lock] => 1691417938:1
[_edit_last] => 1
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 7
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4415
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] => Olanzaget™ (Olanzapine + Fluoxetine) is indicated for the treatment of:
- Acute depressive episodes in Bipolar I Disorder.
- Treatment resistant depression (Major Depressive Disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode).
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Olanzapine + Fluoxetine
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Antipsychotic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[rank_math_primary_category] => 688
[rank_math_primary_filters] => 689
[rank_math_primary_countries] => 40
[getz_products_attributes_0_product_type] => Capsules
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 3mg+25mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 6mg+25mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[post_date_gmt] => 2022-12-28 08:22:46
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => olanzaget
[to_ping] =>
[pinged] =>
[post_modified] => 2023-07-17 10:25:32
[post_modified_gmt] => 2023-07-17 10:25:32
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4384
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
)